SIERRA ONCOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition.

On May 7, 2020, Sierra Oncology, Inc. (the "Company") reported its financial results for the quarter ended March 31, 2020. A copy of the press release issued by the Company is furnished as Exhibit 99.1 to this report.

The information furnished with Item 2.02 of this report, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Exchange Act or under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

                 Exhibit
                 Number                 Description
                 99.1        Press release dated May 7, 2020.




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses